Reference · cited facts
BPC-157
Body Protection Compound-157Half-life No established human half-lifeResearch use · not FDA-approvedReviewed July 2026
Educational information and a math tool only — not medical advice, a dose recommendation, or an endorsement of peptide use. Not FDA-approved for human use. Consult a licensed healthcare provider before starting, stopping, or changing anything.
Class / mechanism
BPC-157 is a synthetic peptide studied primarily in preclinical (cell and animal) models; robust human efficacy data do not exist.
SOURCE [1]
Regulatory status
Not FDA-approved. Placed on the FDA 503A Category-2 bulk-substances list (compounding safety/impurity concerns), then removed from Category 2 in 2026 after the nomination was withdrawn — but NOT approved or added to Category 1, leaving a regulatory gray zone. Under PCAC review (July 2026); revisit as the FDA updates.
FDA · July 2026
Reported half-life
No established human half-life
NO RELIABLE HUMAN SOURCE
Human evidence
Preclinical only
LITERATURE
What the literature reports
- BPC-157 is a synthetic peptide studied primarily in preclinical (cell and animal) models; robust human efficacy data do not exist.
- No established human half-life has been characterized.
- It is not an approved medicine in the US or other major jurisdictions, and its compounding status is unsettled.
Honest caveats
- • Evidence is preclinical — no robust human data exists and no benefit is established.
- • Not FDA-approved; regulatory/compounding status is in flux (the 2026 Category-2 removal is not an approval).
Reconstitution calculator
Enter your own vial size, BAC water and target dose — get exact syringe units.
Sources